Database Query Results : Alpha-Lipoic-Acid, ,

ALA, Alpha-Lipoic-Acid: Click to Expand ⟱
Features: antioxidant, energy production in cell mitochondria
Alpha-Lipoic-Acid: also known as lipoic acid or thioctic acid (reduced form is dihydrolipoic acid).
"Universal antioxidant" because it is both water- and fat-soluble and can neutralize free radicals.
-Treatment sometimes as ALA/N (alpha-lipoic acid/low-dose naltresone)
-Also done in IV
-Decreases ROS production, but also has pro-oxidant role.
Normal adult can take 300 milligrams twice a day with food, but they should always take a B-complex vitamin with it. Because B complex vitamins, especially thiamine, and biotin, and riboflavin, are depleted during this metabolic process.
α-Lipoic acid acts as a chelating agent for metal ions, a quenching agent for reactive oxygen species, and a reducing agent for the oxidized form of glutathione and vitamins C and E.
-It seems a paradox that LA functions as both antioxidant and prooxidant. LA functions the pro-oxidant only in special cancer cells, such as A549 and PC9 cells which should show high-level NRF2 expression and high glycolytic level. Through inhibiting PDK1 to further prohibit NRF2; LA functions as anticancer prooxidant.

α-lipoic acid possesses excellent silver chelating properties.

- ALA acts as pro-Oxidant only in cancer cells:#278 - Pro-Oxidant Dose margin >100uM:#304

- Bioavailability: 80-90%, but conversion to EPA/DHA is 5-10% (and takes longer time).
- AI (Adequate Intake): 1.1-1.6g/day.
- human studies have shown that ALA levels decline significantly with age
- 1g of ALA might achieve 500uM in the blood.
- ALA is poorly soluble, lecithin has been used as an amphiphilic matrix to enhance its bioavailability.
- Pilot studies or observational interventions have used flaxseed supplementation (rich in ALA) in doses providing roughly 3–4 g of ALA daily.
- Flaxseed oil is even more concentrated in ALA – typical 50–60% ALA by weight.
- single walnut may contain 300mg of ALA
- chia oil contains 55-65% ALA.
- α-LA can also be obtained from the diet through the consumption of dark green leafy vegetables and meats
- ALA is more stable in chia seeds, (2grams of ALA per tablespoon)
- ALA degrades when exposed to heat, light, and air. (prone to oxidation)

-Note half-life 1-2 hrs.
BioAv 30-40% from walnuts, 60-80% from supplements. Co-ingestion with fat improves absorption. Both fat and water soluble
Pathways:
- induce ROS production
- ROS↑ related: MMP↓(ΔΨm), ER Stress↑, UPR↑, GRP78↑, Cyt‑c↑, Caspases↑, DNA damage↑,
- Lowers AntiOxidant defense in Cancer Cells: NRF2↓, SOD↓, GSH↓ Catalase↓ HO1↓ GPx↓
- Raises AntiOxidant defense in Normal Cells: ROS↓, NRF2↑, SOD↑, GSH↑, Catalase↑,
- lowers Inflammation : NF-kB↓, COX2↓, Pro-Inflammatory Cytokines : IL-1β↓, TNF-α↓, IL-6↓, IL-8↓
- inhibit Growth/Metastases : TumMeta↓, TumCG↓, EMT↓, MMPs↓, MMP2↓, MMP9↓, IGF-1↓, VEGF↓, FAK↓, NF-κB↓, TGF-β↓, α-SMA↓, ERK↓
- cause Cell cycle arrest : TumCCA↑, cyclin D1↓,
- inhibits Migration/Invasion : TumCMig↓, TumCI↓, TNF-α↓, FAK↓, ERK↓, EMT↓,
- inhibits glycolysis and ATP depletion : HIF-1α↓, PKM2↓, GLUT1↓, LDHA↓, HK2↓, PFKs↓, PDKs↓, ECAR↓, OXPHOS↓, GRP78↑, Glucose↓, GlucoseCon↓
- inhibits angiogenesis↓ : VEGF↓, HIF-1α↓, EGFR↓, Integrins↓,
- small indication of inhibiting Cancer Stem Cells : CSC↓, CD24↓, β-catenin↓,
- Others: PI3K↓, AKT↓, JAK↓, STAT↓, β-catenin↓, AMPK, ERK↓, JNK,
- Synergies: chemo-sensitization, chemoProtective, RadioSensitizer, RadioProtective, Others(review target notes), Neuroprotective, Cognitive, Renoprotection, Hepatoprotective, CardioProtective,

- Selectivity: Cancer Cells vs Normal Cells


Scientific Papers found: Click to Expand⟱
3438- ALA,    The Potent Antioxidant Alpha Lipoic Acid
- Review, NA, NA - Review, AD, NA
"highlight2" >*antiOx↑, "highlight2" >*cardioP↑, "highlight2" >*cognitive↑, "highlight2" >*AntiAge↑, "highlight2" >*Inflam↓, "highlight2" >*AntiCan↑, "highlight2" >*neuroP↑, "highlight2" >*IronCh↑, "highlight2" >*ROS↑, "highlight2" >*Weight↓, "highlight2" >*Ach↑, "highlight2" >*ROS↓, "highlight2" >*GSH↑, "highlight2" >*lipid-P↓, "highlight2" >*memory↑, "highlight2" >*NRF2↑, "highlight2" >*ChAT↑, "highlight2" >*GlucoseCon↑, "highlight2" >*Acetyl-CoA↑,
3448- ALA,    Alpha lipoic acid attenuates hypoxia-induced apoptosis, inflammation and mitochondrial oxidative stress via inhibition of TRPA1 channel in human glioblastoma cell line
"highlight2" >*Inflam↓, "highlight2" >*ROS↓, "highlight2" >*GSH↑, "highlight2" >*GPx↑, "highlight2" >*Casp3↓, "highlight2" >*Casp9↓, "highlight2" >*MMP↑,
3447- ALA,    Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells
- in-vitro, AD, SH-SY5Y
"highlight2" >*ATP↑, "highlight2" >*MMP↑, "highlight2" >*ROS↓, "highlight2" >*GlucoseCon↑, "highlight2" >*GSH↑, "highlight2" >*neuroP↑, "highlight2" >*cognitive↑, "highlight2" >*Ach↑, "highlight2" >*Inflam↓, "highlight2" >*Aβ↓, "highlight2" >OXPHOS↓,
3446- ALA,  CUR,    The Potential Protective Effect of Curcumin and α-Lipoic Acid on N-(4-Hydroxyphenyl) Acetamide-induced Hepatotoxicity Through Downregulation of α-SMA and Collagen III Expression
- in-vivo, Nor, NA
"highlight2" >*hepatoP↑, "highlight2" >*α-SMA↓, "highlight2" >*COL3A1↓, "highlight2" >*ROS↓, "highlight2" >*GSH↑, "highlight2" >*ALAT↓, "highlight2" >*AST↓, "highlight2" >*ALP↓, "highlight2" >*MDA↓,
3445- ALA,  Rad,    The radioprotective effects of alpha-lipoic acid on radiotherapy-induced toxicities: A systematic review
- Review, Var, NA
"highlight2" >*radioP↑, "highlight2" >*antiOx↑, "highlight2" >*Inflam↓,
3444- ALA,    Alpha-Lipoic Acid Nootropic Review: Benefits, Use, Dosage & Side Effects
- Review, NA, NA
"highlight2" >*BBB↑, "highlight2" >*cognitive↑, "highlight2" >*neuroP↑, "highlight2" >*antiOx↑,
3443- ALA,    Molecular and Therapeutic Insights of Alpha-Lipoic Acid as a Potential Molecule for Disease Prevention
- Review, Var, NA - Review, AD, NA
"highlight2" >*antiOx↑, "highlight2" >*ROS↓, "highlight2" >*IronCh↑, "highlight2" >*cognitive↑, "highlight2" >*cardioP↓, "highlight2" >AntiCan↑, "highlight2" >*neuroP↑, "highlight2" >*Inflam↓, "highlight2" >*BioAv↓, "highlight2" >*AntiAge↑, "highlight2" >*Half-Life↓, "highlight2" >*BioAv↝, "highlight2" >other↝, "highlight2" >EGFR↓, "highlight2" >Akt↓, "highlight2" >ROS↓, "highlight2" >TumCCA↑, "highlight2" >p27↑, "highlight2" >PDH↑, "highlight2" >Glycolysis↓, "highlight2" >ROS↑, "highlight2" >*eff↑, "highlight2" >*memory↑, "highlight2" >*motorD↑, "highlight2" >*GutMicro↑,
3442- ALA,    α‑lipoic acid modulates prostate cancer cell growth and bone cell differentiation
- in-vitro, Pca, 22Rv1 - in-vitro, Pca, C4-2B - in-vitro, Nor, 3T3
"highlight2" >tumCV↓, "highlight2" >TumCMig↓, "highlight2" >TumCI↓, "highlight2" >ROS↑, "highlight2" >Hif1a↑, "highlight2" >JNK↑, "highlight2" >Casp↑, "highlight2" >TumCCA↑, "highlight2" >Apoptosis↑, "highlight2" >selectivity↑,
3441- ALA,    α-Lipoic Acid Maintains Brain Glucose Metabolism via BDNF/TrkB/HIF-1α Signaling Pathway in P301S Mice
- in-vivo, AD, NA
"highlight2" >*tau↓, "highlight2" >*GlucoseCon↑, "highlight2" >*GLUT3↑, "highlight2" >*GLUT4↑, "highlight2" >*VEGF↑, "highlight2" >*HO-1↑, "highlight2" >*Glycolysis↑, "highlight2" >*HK1↑, "highlight2" >*PGC-1α↑, "highlight2" >*Hif1a↑, "highlight2" >*neuroP↑,
3440- ALA,    Protective effects of alpha lipoic acid (ALA) are mediated by hormetic mechanisms
- Review, AD, NA
"highlight2" >*ROS↓, "highlight2" >*neuroP↑, "highlight2" >*Aβ↓, "highlight2" >*cardioP?,
3439- ALA,    The effect of alpha lipoic acid on the developmental competence of mouse isolated preantral follicles
- in-vitro, NA, NA
"highlight2" >*ROS↓, "highlight2" >*TAC↑, "highlight2" >*eff↑, "highlight2" >*SOD↑, "highlight2" >*GPx↑, "highlight2" >*Catalase↑, "highlight2" >*GlucoseCon↑, "highlight2" >*antiOx↑,
3449- ALA,    Alpha-Lipoic Acid Downregulates IL-1β and IL-6 by DNA Hypermethylation in SK-N-BE Neuroblastoma Cells
- in-vitro, AD, SK-N-BE
"highlight2" >*antiOx↑, "highlight2" >*NRF2↑, "highlight2" >*NF-kB↓, "highlight2" >*IL1β↓, "highlight2" >*IL6↓, "highlight2" >neuroP↑,
3437- ALA,    Revisiting the molecular mechanisms of Alpha Lipoic Acid (ALA) actions on metabolism
- Review, Var, NA
"highlight2" >*IronCh↑, "highlight2" >*antiOx↑, "highlight2" >*ROS↓, "highlight2" >*GSH↑, "highlight2" >*NF-kB↓, "highlight2" >*AMPK⇅, "highlight2" >*FAO↑, "highlight2" >*GlucoseCon↑, "highlight2" >*PI3K↑, "highlight2" >*Akt?,
3436- ALA,    Alpha lipoic acid modulates metabolic reprogramming in breast cancer stem cells enriched 3D spheroids by targeting phosphoinositide 3-kinase: In silico and in vitro insights Author links open overlay panel
- in-vitro, BC, MCF-7
"highlight2" >ChemoSen↑, "highlight2" >PI3K↓, "highlight2" >Akt↓, "highlight2" >ATP↓, "highlight2" >GlucoseCon↓, "highlight2" >ROS↑, "highlight2" >PKM2↓, "highlight2" >Glycolysis↓, "highlight2" >CSCs↓, "highlight2" >IGF-1R↓, "highlight2" >Furin↓, "highlight2" >RadioS↑,
3434- ALA,    Alpha lipoic acid modulates metabolic reprogramming in breast cancer stem cells enriched 3D spheroids by targeting phosphoinositide 3-kinase: In silico and in vitro insights
- in-vitro, BC, MCF-7 - in-vitro, BC, MDA-MB-231
"highlight2" >tumCV↓, "highlight2" >PI3K↓, "highlight2" >p‑Akt↓, "highlight2" >p‑P70S6K↓, "highlight2" >mTOR↓, "highlight2" >ATP↓, "highlight2" >GlucoseCon↓, "highlight2" >ROS↑, "highlight2" >PKM2↓, "highlight2" >LDHA↓, "highlight2" >Glycolysis↓, "highlight2" >ChemoSen↑,
3433- ALA,    Alpha lipoic acid promotes development of hematopoietic progenitors derived from human embryonic stem cells by antagonizing ROS signals
"highlight2" >*ROS↓, "highlight2" >*Apoptosis↓, "highlight2" >*Hif1a↑, "highlight2" >*FOXO1↑, "highlight2" >*FOXO3↑, "highlight2" >*ATM↑, "highlight2" >*SIRT1↑, "highlight2" >*SIRT3↑, "highlight2" >*CD34↑,
3284- ALA,    Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson's Disease Model Induced by 6-OHDA
- vitro+vivo, Park, NA
"highlight2" >*antiOx↑, "highlight2" >*IronCh↑, "highlight2" >*neuroP↑, "highlight2" >*ROS↓, "highlight2" >*Iron↓, "highlight2" >*BBB↑, "highlight2" >*motorD↑, "highlight2" >*GSH↑,
3283- ALA,    Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells
- in-vitro, Nor, NA
"highlight2" >*TNF-α↓, "highlight2" >*NF-kB↓, "highlight2" >*antiOx↑, "highlight2" >*IronCh↑, "highlight2" >*GSSG↓, "highlight2" >*VCAM-1↓, "highlight2" >*E-sel↓, "highlight2" >*ICAM-1↓, "highlight2" >*MCP1↓, "highlight2" >*NF-kB↓, "highlight2" >IKKα↓,
3272- ALA,    Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
- Review, AD, NA
"highlight2" >*antiOx↑, "highlight2" >*glucose↑, "highlight2" >*eNOS↑, "highlight2" >*NRF2↑, "highlight2" >*MMP9↓, "highlight2" >*VCAM-1↓, "highlight2" >*NF-kB↓, "highlight2" >*cardioP↑, "highlight2" >*cognitive↑, "highlight2" >*eff↓, "highlight2" >*BBB↑, "highlight2" >*IronCh↑, "highlight2" >*GSH↑, "highlight2" >*PKCδ↑, "highlight2" >*ERK↑, "highlight2" >*p38↑, "highlight2" >*MAPK↑, "highlight2" >*PI3K↑, "highlight2" >*Akt↑, "highlight2" >*PTEN↓, "highlight2" >*AMPK↑, "highlight2" >*GLUT4↑, "highlight2" >*GLUT1↑, "highlight2" >*Inflam↓,
3271- ALA,    Decrypting the potential role of α-lipoic acid in Alzheimer's disease
- Review, AD, NA
"highlight2" >*antiOx↑, "highlight2" >*memory↑, "highlight2" >*neuroP↑, "highlight2" >*Inflam↓, "highlight2" >*IronCh↑, "highlight2" >*NRF2↑, "highlight2" >*BBB↑, "highlight2" >*GlucoseCon↑, "highlight2" >*Ach↑, "highlight2" >*ROS↓, "highlight2" >*p‑tau↓, "highlight2" >*Aβ↓, "highlight2" >*cognitive↑, "highlight2" >*Hif1a↑, "highlight2" >*Ca+2↓, "highlight2" >*GLUT3↑, "highlight2" >*GLUT4↑, "highlight2" >*HO-1↑, "highlight2" >*VEGF↑, "highlight2" >*PDKs↓, "highlight2" >*PDH↑, "highlight2" >*VCAM-1↓, "highlight2" >*GSH↑, "highlight2" >*NRF2↑, "highlight2" >*hepatoP↑, "highlight2" >*ChAT↑,
3270- ALA,    Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis
- Trial, AD, NA
"highlight2" >*cognitive↑, "highlight2" >*other↝, "highlight2" >*neuroP↑, "highlight2" >*IronCh↑, "highlight2" >*ROS↓, "highlight2" >*GSH↑,
3269- ALA,    Sulfur-containing therapeutics in the treatment of Alzheimer’s disease
- NA, AD, NA
"highlight2" >*AChE↓, "highlight2" >*GlucoseCon↑, "highlight2" >*ACC↑, "highlight2" >*GSH↑, "highlight2" >*Aβ↓, "highlight2" >*Catalase↑, "highlight2" >*GSR↑, "highlight2" >*GSTs↑, "highlight2" >*NADPH↑, "highlight2" >*NQO1↑, "highlight2" >*iNOS↓, "highlight2" >*NF-kB↓, "highlight2" >*lipid-P↓, "highlight2" >*BBB↑, "highlight2" >*memory↑, "highlight2" >*cognitive↑, "highlight2" >*antiOx↑, "highlight2" >*Inflam↓,
3543- ALA,    The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease
- Study, AD, NA
"highlight2" >*cognitive↑, "highlight2" >*antiOx↑, "highlight2" >*Inflam↓, "highlight2" >*neuroP↑, "highlight2" >*Ach↑, "highlight2" >*ROS↓, "highlight2" >*GlucoseCon↑, "highlight2" >*lipid-P↓, "highlight2" >*GSH↑, "highlight2" >*Acetyl-CoA↑,
4282- ALA,    Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial
- Trial, NA, NA
"highlight2" >*antiOx↑, "highlight2" >*Inflam↓, "highlight2" >*lipid-P↓, "highlight2" >*adiP↑, "highlight2" >*cognitive∅, "highlight2" >*BDNF↑,
3552- ALA,    The dietary fatty acids α-linolenic acid (ALA) and linoleic acid (LA) selectively inhibit microglial nitric oxide production
- in-vitro, AD, BV2
"highlight2" >*NO↓, "highlight2" >*cognitive↑,
3551- ALA,    Alpha lipoic acid treatment in late middle age improves cognitive function: Proteomic analysis of the protective mechanisms in the hippocampus
- in-vivo, AD, NA
"highlight2" >*cognitive↑, "highlight2" >*Apoptosis↓, "highlight2" >*Inflam↓, "highlight2" >*antiOx↑, "highlight2" >*BioAv↝, "highlight2" >*neuroP↑,
3550- ALA,    Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease?
- Review, AD, NA
"highlight2" >*antiOx↑, "highlight2" >*Inflam↓, "highlight2" >*PGE2↓, "highlight2" >*COX2↓, "highlight2" >*iNOS↓, "highlight2" >*TNF-α↓, "highlight2" >*IL1β↓, "highlight2" >*IL6↓, "highlight2" >*BioAv↓, "highlight2" >*Ach↑, "highlight2" >*ROS↓, "highlight2" >*cognitive↑, "highlight2" >*neuroP↑, "highlight2" >*BBB↑, "highlight2" >*Half-Life↓, "highlight2" >*BioAv↑, "highlight2" >*Casp3↓, "highlight2" >*Casp9↓, "highlight2" >*ChAT↑, "highlight2" >*cognitive↑, "highlight2" >*eff↑, "highlight2" >*cAMP↑, "highlight2" >*IL2↓, "highlight2" >*INF-γ↓, "highlight2" >*TNF-α↓, "highlight2" >*SIRT1↑, "highlight2" >*SOD↑, "highlight2" >*GPx↑, "highlight2" >*MDA↓, "highlight2" >*NRF2↑,
3549- ALA,    Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia
- Review, AD, NA
"highlight2" >*Inflam↓, "highlight2" >*other↝, "highlight2" >*other↝, "highlight2" >*neuroP↑, "highlight2" >*BioAv↝, "highlight2" >*adiP↑, "highlight2" >*BBB↑, "highlight2" >*Casp6↓, "highlight2" >*Casp9↓, "highlight2" >*TNF-α↓, "highlight2" >*IL6↓, "highlight2" >*IL1β↓, "highlight2" >*ROS↓, "highlight2" >*NO↓, "highlight2" >*iNOS↓, "highlight2" >*COX2↓, "highlight2" >*JNK↓, "highlight2" >*p‑NF-kB↓, "highlight2" >*Aβ↓, "highlight2" >*BP↓, "highlight2" >*memory↑, "highlight2" >*cAMP↑, "highlight2" >*ERK↑, "highlight2" >*Akt↑, "highlight2" >cognitive?,
3548- ALA,    How Alpha Linolenic Acid May Sustain Blood–Brain Barrier Integrity and Boost Brain Resilience against Alzheimer’s Disease
- Review, AD, NA
"highlight2" >*BBB↑, "highlight2" >*other↑, "highlight2" >*other↑,
3547- ALA,    Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration
- Review, AD, NA - Review, Park, NA
"highlight2" >*memory↑, "highlight2" >*neuroP↑, "highlight2" >*motorD↑, "highlight2" >*VitC↑, "highlight2" >*VitE↑, "highlight2" >*GSH↑, "highlight2" >*SOD↑, "highlight2" >*Catalase↑, "highlight2" >*GPx↑, "highlight2" >*5HT↑, "highlight2" >*lipid-P↓, "highlight2" >*IronCh↑, "highlight2" >*AChE↓, "highlight2" >*Inflam↓, "highlight2" >*GlucoseCon↑, "highlight2" >*GLUT3↑, "highlight2" >*GLUT4↑, "highlight2" >NF-kB↓, "highlight2" >*IGF-1↑, "highlight2" >*IL1β↓, "highlight2" >*TNF-α↓, "highlight2" >*cognitive↑, "highlight2" >*ChAT↑, "highlight2" >*HO-1↑, "highlight2" >*NQO1↑,
3546- ALA,    Cognitive and Mood Effect of Alpha-Lipoic Acid Supplementation in a Nonclinical Elder Sample: An Open-Label Pilot Study
- Study, AD, NA
"highlight2" >*antiOx↑, "highlight2" >*ROS↓, "highlight2" >*cognitive∅, "highlight2" >*lipid-P↓, "highlight2" >*memory↑, "highlight2" >*ChAT↑, "highlight2" >*Acetyl-CoA↑, "highlight2" >*Aβ↓, "highlight2" >*BioAv↑, "highlight2" >*BBB↑, "highlight2" >*toxicity∅,
3545- ALA,    Potential therapeutic effects of alpha lipoic acid in memory disorders
- Review, AD, NA
"highlight2" >*neuroP↑, "highlight2" >*Inflam↓, "highlight2" >*VCAM-1↓, "highlight2" >*5HT↑, "highlight2" >*memory↑, "highlight2" >*BioAv↝, "highlight2" >*Half-Life↓, "highlight2" >*NF-kB↓, "highlight2" >*antiOx↑, "highlight2" >*IronCh↑, "highlight2" >*ROS↓, "highlight2" >*ATP↑, "highlight2" >*ChAT↑, "highlight2" >*Ach↑, "highlight2" >*cognitive↑, "highlight2" >*lipid-P↓, "highlight2" >*VitC↑, "highlight2" >*VitE↑, "highlight2" >*GSH↑, "highlight2" >*SOD↑, "highlight2" >*Catalase↑, "highlight2" >*GPx↑, "highlight2" >*Aβ↓,
3544- ALA,    Alpha lipoic acid for dementia
- Review, AD, NA
"highlight2" >*antiOx↑, "highlight2" >*BBB↑, "highlight2" >*VitC↑, "highlight2" >*VitE↑, "highlight2" >*GSH↑, "highlight2" >*IronCh↑, "highlight2" >*neuroP↑, "highlight2" >*NO↓, "highlight2" >*cognitive↑, "highlight2" >*AntiAge↑, "highlight2" >*memory↑, "highlight2" >*ROS↓,
259- ALA,    Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells
- in-vitro, Liver, HepG2 - in-vitro, Liver, FaO
"highlight2" >Cyc↓, "highlight2" >P21↑, "highlight2" >ROS↑, "highlight2" >p‑P53↑, "highlight2" >BAX↑, "highlight2" >Cyt‑c↑, "highlight2" >Casp↑, "highlight2" >survivin↓, "highlight2" >JNK↑, "highlight2" >Akt↓,
3542- ALA,    Chelation: Harnessing and Enhancing Heavy Metal Detoxification—A Review
- Review, Var, NA
"highlight2" >*antiOx↑, "highlight2" >*VitE↑, "highlight2" >*VitC↑, "highlight2" >*GSH↑, "highlight2" >*IronCh↑, "highlight2" >*BioAv↑, "highlight2" >*BBB↑,
3541- ALA,    Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology
- Review, Var, NA
"highlight2" >*antiOx↑, "highlight2" >*IronCh↑, "highlight2" >*GSH↑, "highlight2" >*BBB↑, "highlight2" >Apoptosis↑, "highlight2" >MMP↓, "highlight2" >ROS↑, "highlight2" >lipid-P↑, "highlight2" >PARP1↑, "highlight2" >Casp3↑, "highlight2" >Casp9↑, "highlight2" >*NRF2↑, "highlight2" >*GSH↑, "highlight2" >*ROS↓, "highlight2" >RenoP↑, "highlight2" >ChemoSen↑, "highlight2" >*BG↓,
3540- ALA,    Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant?
- in-vitro, NA, NA
"highlight2" >*lipid-P↓, "highlight2" >*H2O2↓, "highlight2" >*IronCh↑,
3539- ALA,    Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
- Review, AD, NA
"highlight2" >*ROS↓, "highlight2" >*IronCh↑, "highlight2" >*GSH↑, "highlight2" >*antiOx↑, "highlight2" >*NRF2↑, "highlight2" >*MMP9↓, "highlight2" >*VCAM-1↓, "highlight2" >*NF-kB↓, "highlight2" >*cognitive↑, "highlight2" >*Inflam↓, "highlight2" >*BioAv↝, "highlight2" >*BioAv↝, "highlight2" >*BBB↑, "highlight2" >*H2O2∅, "highlight2" >*neuroP↑, "highlight2" >*PKCδ↑, "highlight2" >*ERK↑, "highlight2" >*MAPK↑, "highlight2" >*PI3K↑, "highlight2" >*Akt↑, "highlight2" >*PTEN↓, "highlight2" >*AMPK↑, "highlight2" >*GLUT4↑, "highlight2" >*GlucoseCon↑, "highlight2" >*BP↝, "highlight2" >*eff↑, "highlight2" >*ICAM-1↓, "highlight2" >*VCAM-1↓, "highlight2" >*Dose↝,
3456- ALA,    Renal-Protective Roles of Lipoic Acid in Kidney Disease
- Review, NA, NA
"highlight2" >*RenoP↑, "highlight2" >*ROS↓, "highlight2" >*antiOx↑, "highlight2" >*Inflam↓, "highlight2" >*Sepsis↓, "highlight2" >*IronCh↑, "highlight2" >*BUN↓, "highlight2" >*creat↓, "highlight2" >*TNF-α↓, "highlight2" >*IL6↓, "highlight2" >*IL1β↓, "highlight2" >*MDA↓, "highlight2" >*NRF2↑, "highlight2" >*HO-1↑, "highlight2" >*NQO1↑, "highlight2" >*chemoP↑, "highlight2" >*eff↑, "highlight2" >*NF-kB↓,
3455- ALA,    Alpha-lipoic acid inhibits proliferation and migration of human vascular endothelial cells through downregulating HSPA12B/VEGF signaling axis
- in-vitro, Nor, HUVECs
"highlight2" >*cMyc↓, "highlight2" >*VEGF↓, "highlight2" >*eNOS↓, "highlight2" >angioG↓,
3454- ALA,    Lipoic acid blocks autophagic flux and impairs cellular bioenergetics in breast cancer and reduces stemness
- in-vitro, BC, MCF-7 - in-vitro, BC, MDA-MB-231
"highlight2" >TumCG↑, "highlight2" >Glycolysis↓, "highlight2" >ROS↑, "highlight2" >CSCs↓, "highlight2" >selectivity↑, "highlight2" >LC3B-II↑, "highlight2" >MMP↓, "highlight2" >mitResp↓, "highlight2" >ATP↓, "highlight2" >OCR↓, "highlight2" >NAD↓, "highlight2" >p‑AMPK↑, "highlight2" >GlucoseCon↓, "highlight2" >lactateProd↓, "highlight2" >HK2↓, "highlight2" >PFK↓, "highlight2" >LDHA↓, "highlight2" >eff↓, "highlight2" >mTOR↓, "highlight2" >ECAR↓, "highlight2" >ALDH↓, "highlight2" >CD44↓, "highlight2" >CD24↓,
3451- ALA,    Alpha-lipoic acid ameliorates H2O2-induced human vein endothelial cells injury via suppression of inflammation and oxidative stress
- in-vitro, Nor, HUVECs
"highlight2" >*LDH↓, "highlight2" >*NOX4↓, "highlight2" >*NF-kB↓, "highlight2" >*iNOS↓, "highlight2" >*VCAM-1↓, "highlight2" >*ICAM-1↓, "highlight2" >*ROS↓, "highlight2" >*cardioP↑,
3450- ALA,    α-Lipoic Acid Inhibits Expression of IL-8 by Suppressing Activation of MAPK, Jak/Stat, and NF-κB in H. pylori-Infected Gastric Epithelial AGS Cells
- in-vitro, NA, AGS
"highlight2" >*IL8↓, "highlight2" >*MAPK↓, "highlight2" >*JAK↓, "highlight2" >*STAT↓, "highlight2" >*NF-kB↓,
272- ALA,    Evidence that α-lipoic acid inhibits NF-κB activation independent of its antioxidant function
- in-vitro, NA, HUVECs
"highlight2" >NF-kB↓,
284- ALA,    Lipoic acid a multi-level molecular inhibitor of tumorigenesis
- Review, Var, NA
"highlight2" >EMT↓, "highlight2" >TumMeta↓,
283- ALA,    alpha-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells
- in-vitro, BC, MDA-MB-231
"highlight2" >MMP2↓, "highlight2" >MMP9↓, "highlight2" >TumMeta↓,
282- ALA,    Alpha-lipoic acid induced apoptosis of PC3 prostate cancer cells through an alteration on mitochondrial membrane depolarization and MMP-9 mRNA expression
- in-vitro, Pca, PC3
"highlight2" >MMP↓, "highlight2" >Casp↑, "highlight2" >MMP9↓,
281- ALA,    Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation
- in-vitro, Lung, H460
"highlight2" >mt-ROS↑, "highlight2" >Apoptosis↑, "highlight2" >Casp9↑, "highlight2" >Bcl-2↓, "highlight2" >eff↓, "highlight2" >eff↑, "highlight2" >H2O2↑, "highlight2" >Dose↑,
280- ALA,    Alpha‐lipoic acid inhibits lung cancer growth via mTOR‐mediated autophagy inhibition
- in-vivo, Lung, A549
"highlight2" >p‑mTOR↑, "highlight2" >TumCG↓, "highlight2" >TumAuto↓, "highlight2" >p‑P70S6K↑,
279- ALA,    Lipoic acid-induced oxidative stress abrogates IGF-1R maturation by inhibiting the CREB/furin axis in breast cancer cell lines
- in-vitro, BC, MCF-7 - in-vitro, BC, MDA-MB-231
"highlight2" >Furin↓, "highlight2" >IGF-1R↓, "highlight2" >ROS↑, "highlight2" >CREB↓, "highlight2" >Furin↓, "highlight2" >IGF-1R↓,
278- ALA,    The Multifaceted Role of Alpha-Lipoic Acid in Cancer Prevention, Occurrence, and Treatment
- Review, NA, NA
"highlight2" >ROS↑, "highlight2" >NRF2↑, "highlight2" >Inflam↓, "highlight2" >frataxin↑, "highlight2" >*BioAv↓, "highlight2" >ChemoSen↑, "highlight2" >Hif1a↓, "highlight2" >eff↑, "highlight2" >FAK↓, "highlight2" >ITGB1↓, "highlight2" >MMP2↓, "highlight2" >MMP9↓, "highlight2" >EMT↓, "highlight2" >Snail↓, "highlight2" >Vim↓, "highlight2" >Zeb1↓, "highlight2" >P53↑, "highlight2" >MGMT↓, "highlight2" >Mcl-1↓, "highlight2" >Bcl-xL↓, "highlight2" >Bcl-2↓, "highlight2" >survivin↓, "highlight2" >Casp3↑, "highlight2" >Casp9↑, "highlight2" >BAX↑, "highlight2" >p‑Akt↓, "highlight2" >GSK‐3β↓, "highlight2" >*antiOx↑, "highlight2" >*ROS↓, "highlight2" >selectivity↑, "highlight2" >angioG↓, "highlight2" >MMPs↓, "highlight2" >NF-kB↓, "highlight2" >ITGB3↓, "highlight2" >NADPH↓,
277- ALA,    α-lipoic acid modulates prostate cancer cell growth and bone cell differentiation
- in-vitro, Pca, 22Rv1 - in-vitro, Pca, C4-2B
"highlight2" >ROS↑, "highlight2" >Hif1a↑, "highlight2" >JNK↑, "highlight2" >Casp3↑, "highlight2" >P21↑, "highlight2" >BAX↑, "highlight2" >Bcl-xL↓, "highlight2" >cFos↓,
276- ALA,    Alpha lipoic acid diminishes migration and invasion in hepatocellular carcinoma cells through an AMPK-p53 axis
- in-vitro, HCC, HepG2 - in-vitro, HCC, Hep3B
"highlight2" >P53↑, "highlight2" >EMT↓, "highlight2" >AMPK↑, "highlight2" >cycD1/CCND1↓, "highlight2" >TumCMig↓,
274- ALA,  LDN,    Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases
- Human, PC, NA
"highlight2" >OS↑,
285- ALA,  HCA,    Tolerance of oral lipoid acid and hydroxycitrate combination in cancer patients: first approach of the cancer metabolism research group
- Human, Var, NA
"highlight2" >PI3K↝, "highlight2" >AMPK↝, "highlight2" >TumCG↓, "highlight2" >*toxicity↓, "highlight2" >Weight∅,
271- ALA,  VitC,  LDN,    The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol
"highlight2" >OS↑, "highlight2" >Weight↑, "highlight2" >TumVol↓,
267- ALA,    α-Lipoic Acid Targeting PDK1/NRF2 Axis Contributes to the Apoptosis Effect of Lung Cancer Cells
- vitro+vivo, Lung, A549 - vitro+vivo, Lung, PC9
"highlight2" >Apoptosis↑, "highlight2" >ROS↑, "highlight2" >PDK1↓, "highlight2" >NRF2↓, "highlight2" >PDK1↓, "highlight2" >Bcl-2↓, "highlight2" >Casp9↑, "highlight2" >Dose∅,
266- ALA,    Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death
- in-vitro, Ovarian, IGROV1
"highlight2" >Mcl-1↓, "highlight2" >Bcl-xL↓, "highlight2" >BIM↑, "highlight2" >ROS↑,
265- ALA,    Alpha-Lipoic Acid Reduces Cell Growth, Inhibits Autophagy, and Counteracts Prostate Cancer Cell Migration and Invasion: Evidence from In Vitro Studies
- in-vitro, Pca, LNCaP - in-vitro, Pca, DU145
"highlight2" >ROS↓, "highlight2" >SOD↓, "highlight2" >GSTP1/GSTπ↓, "highlight2" >NRF2↓, "highlight2" >p62↓, "highlight2" >p62↑, "highlight2" >SOD↑, "highlight2" >p‑mTOR↑, "highlight2" >Beclin-1↓, "highlight2" >ROS↑, "highlight2" >SOD1↑,
264- ALA,    α-Lipoic acid induces Endoplasmic Reticulum stress-mediated apoptosis in hepatoma cells
- in-vitro, HCC, FaO
"highlight2" >ROS↑, "highlight2" >P53↑, "highlight2" >ER Stress↑, "highlight2" >UPR↑, "highlight2" >CHOP↑, "highlight2" >PDI↑, "highlight2" >GRP78/BiP↑, "highlight2" >GRP58↓,
263- ALA,    Alpha-lipoic acid induces p27Kip-dependent cell cycle arrest in non-transformed cell lines and apoptosis in tumor cell lines
- in-vitro, SCC, Jurkat - in-vitro, SCC, FaDu
"highlight2" >p27↑,
262- ALA,    Lipoic acid decreases breast cancer cell proliferation by inhibiting IGF-1R via furin downregulation
- in-vitro, BC, MCF-7 - in-vitro, BC, MDA-MB-231
"highlight2" >TumCP↓, "highlight2" >Akt↓, "highlight2" >ERK↓, "highlight2" >IGF-1R↓, "highlight2" >Furin↓, "highlight2" >Ki-67↓, "highlight2" >AMPK↑, "highlight2" >mTOR↓,
261- ALA,    The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells
- in-vitro, BC, MCF-7
"highlight2" >ROS↓, "highlight2" >Akt↓, "highlight2" >p27↑, "highlight2" >Bax:Bcl2↑,
260- ALA,    The effects of alpha-lipoic acid on breast of female albino rats exposed to malathion: Histopathological and immunohistochemical study
- in-vivo, BC, NA
"highlight2" >PCNA↓, "highlight2" >P53↓, "highlight2" >Apoptosis↑, "highlight2" >BAX↑,
258- ALA,    Effects of α-lipoic acid on cell proliferation and apoptosis in MDA-MB-231 human breast cells
- in-vitro, BC, MDA-MB-231
"highlight2" >TumCG↓, "highlight2" >p‑Akt↓, "highlight2" >Akt↓, "highlight2" >HER2/EBBR2↓, "highlight2" >Bcl-2↓, "highlight2" >BAX↑, "highlight2" >Casp3↑,
296- ALA,    Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivo
- vitro+vivo, neuroblastoma, SK-N-SH - vitro+vivo, BC, SkBr3
"highlight2" >TumCG↓, "highlight2" >Casp3↑,
304- ALA,    alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation
- in-vitro, Colon, HT-29
"highlight2" >mt-ROS↑, "highlight2" >Apoptosis↑, "highlight2" >Casp3↑, "highlight2" >DNAdam↑, "highlight2" >Bcl-xL↓, "highlight2" >Dose↝,
303- ALA,  LDN,    The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol

302- ALA,    The Antioxidant Alpha-Lipoic Acid Inhibits Proliferation and Invasion of Human Gastric Cancer Cells via Suppression of STAT3-Mediated MUC4 Gene Expression
- in-vitro, GC, AGS - in-vitro, GC, BGC-823 - in-vitro, GC, MKN-28
"highlight2" >MUC4↓, "highlight2" >STAT3↓,
301- ALA,  PacT,  doxoR,    Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients
- Human, BC, NA
"highlight2" >BNP↓, "highlight2" >TNF-α↓, "highlight2" >MDA↓, "highlight2" >NeuroT↓,
1124- ALA,    Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells
- in-vitro, Thyroid, BCPAP - in-vitro, Thyroid, HTH-83 - in-vitro, Thyroid, CAL-62 - in-vitro, Thyroid, FTC-133 - in-vivo, NA, NA
"highlight2" >TumCP↓, "highlight2" >AMPK↑, "highlight2" >mTOR↓, "highlight2" >TumCMig↓, "highlight2" >TumCI↓, "highlight2" >EMT↓, "highlight2" >E-cadherin↑, "highlight2" >β-catenin/ZEB1↓, "highlight2" >Vim↓, "highlight2" >Snail↓, "highlight2" >Twist↓, "highlight2" >TGF-β↓, "highlight2" >p‑SMAD2↓, "highlight2" >TumCG↓,
299- ALA,  Cisplatin,  PacT,    Anti-cancer effects of alpha lipoic acid, cisplatin and paclitaxel combination in the OVCAR-3 ovarian adenocarcinoma cell line
- in-vitro, Ovarian, OVCAR-3
"highlight2" >MMP9↓, "highlight2" >MMP11↓, "highlight2" >MAPK↓,
298- ALA,  Rad,    Synergistic Tumoricidal Effects of Alpha-Lipoic Acid and Radiotherapy on Human Breast Cancer Cells via HMGB1
- in-vitro, BC, MDA-MB-231
"highlight2" >Apoptosis↑, "highlight2" >P53↑, "highlight2" >p38↑, "highlight2" >NF-kB↑, "highlight2" >TumCCA↑,
297- ALA,    Insights on the Use of α-Lipoic Acid for Therapeutic Purposes
- Review, BC, SkBr3 - Review, neuroblastoma, SK-N-SH - Review, AD, NA
"highlight2" >PDH↑, "highlight2" >TumCG↓, "highlight2" >ROS↑, "highlight2" >AMPK↑, "highlight2" >EGR4↓, "highlight2" >Half-Life↓, "highlight2" >BioAv↝, "highlight2" >*GSH↑, "highlight2" >*IronCh↑, "highlight2" >*ROS↓, "highlight2" >*antiOx↑, "highlight2" >*neuroP↑, "highlight2" >*Ach↑, "highlight2" >*lipid-P↓, "highlight2" >*IL1β↓, "highlight2" >*IL6↓, "highlight2" >TumCP↓, "highlight2" >FDG↓, "highlight2" >Apoptosis↑, "highlight2" >AMPK↑, "highlight2" >mTOR↓, "highlight2" >EGFR↓, "highlight2" >TumCI↓, "highlight2" >TumCMig↓, "highlight2" >*memory↑, "highlight2" >*BioAv↑, "highlight2" >*BioAv↝, "highlight2" >*other↓, "highlight2" >*other↝, "highlight2" >*Half-Life↓, "highlight2" >*BioAv↑, "highlight2" >*ChAT↑, "highlight2" >*GlucoseCon↑,
295- ALA,    α-Lipoic acid suppresses migration and invasion via downregulation of cell surface β1-integrin expression in bladder cancer cells
- in-vitro, Bladder, T24
"highlight2" >ITGB1↓, "highlight2" >TumCMig↓, "highlight2" >ERK↓, "highlight2" >Akt↓,
291- ALA,  HCA,  MET,  Dicl,    Metabolic therapies inhibit tumor growth in vivo and in silico
- in-vivo, Melanoma, B16-F10 - in-vivo, Lung, LL/2 (LLC1) - in-vivo, Bladder, MBT-2
"highlight2" >TumCG↓,
290- ALA,  HCA,    A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results
- vitro+vivo, Melanoma, B16-F10
"highlight2" >TumCG↓, "highlight2" >OS↑,
289- ALA,  HCA,  EA,    Cancer Metabolism: Fasting Reset, the Keto-Paradox and Drugs for Undoing
- Analysis, NA, NA
"highlight2" >ACLY↓,
288- ALA,  HCA,  CAP,  Octr,    Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin
"highlight2" >TumCG↓,
287- ALA,  HCA,  Lyco,    Metabolic treatment of cancer: intermediate results of a prospective case series
"highlight2" >PSA↓, "highlight2" >OS↑,
1235- ALA,  Cisplatin,    α-Lipoic acid prevents against cisplatin cytotoxicity via activation of the NRF2/HO-1 antioxidant pathway
- in-vitro, Nor, HEI-OC1 - ex-vivo, NA, NA
"highlight2" >ROS↑, "highlight2" >HO-1↓, "highlight2" >*toxicity↓, "highlight2" >chemoP↑, "highlight2" >*ROS↓, "highlight2" >*HO-1↑, "highlight2" >*SOD1↑, "highlight2" >*NRF2↑,
1628- HCA,  ALA,    Addition of Hydroxy Citrate improves effect of ALA
- Review, Var, NA
"highlight2" >ACLY↓, "highlight2" >other↓, "highlight2" >ROS↑, "highlight2" >eff↑, "highlight2" >PDKs↓,
286- HCA,  ALA,    Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report
"highlight2" >OS↑,
1255- PI,  ALA,    Antileukemic effects of piperlongumine and alpha lipoic acid combination on Jurkat, MEC1 and NB4 cells in vitro
- in-vitro, CLL, NA
"highlight2" >COX2↓, "highlight2" >Casp3↑,
375- SNP,  ALA,    Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pancreatic Cancer
- in-vitro, PC, Bxpc-3 - in-vitro, PC, PANC1 - in-vitro, PC, MIA PaCa-2 - in-vivo, NA, NA
"highlight2" >mtDam↑, "highlight2" >ROS↑, "highlight2" >*toxicity↓, "highlight2" >Dose∅, "highlight2" >selectivity↑,
609- VitC,  ALA,  VitK3,  Se,    Vitamin C and Cancer: Is There A Use For Oral Vitamin C?
"highlight2" >OS↑,
300- VitC,  ALA,    Combination of High-Dose Parenteral Ascorbate (Vitamin C) and Alpha-Lipoic Acid Failed to Enhance Tumor-Inhibitory Effect But Increased Toxicity in Preclinical Cancer Models
- in-vitro, BC, MDA-MB-231 - in-vitro, Colon, HCT116 - in-vitro, Ovarian, PANC1 - in-vitro, Pca, PC3
"highlight2" >TumCG∅,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 87

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

frataxin↑, 1,   GSTP1/GSTπ↓, 1,   H2O2↑, 1,   HO-1↓, 1,   lipid-P↑, 1,   MDA↓, 1,   NRF2↓, 2,   NRF2↑, 1,   OXPHOS↓, 1,   ROS↓, 3,   ROS↑, 18,   mt-ROS↑, 2,   SOD↓, 1,   SOD↑, 1,   SOD1↑, 1,  

Mitochondria & Bioenergetics

ATP↓, 3,   mitResp↓, 1,   MMP↓, 3,   mtDam↑, 1,   OCR↓, 1,  

Core Metabolism/Glycolysis

ACLY↓, 2,   AMPK↑, 5,   AMPK↝, 1,   p‑AMPK↑, 1,   CREB↓, 1,   ECAR↓, 1,   FDG↓, 1,   GlucoseCon↓, 3,   Glycolysis↓, 4,   HK2↓, 1,   lactateProd↓, 1,   LDHA↓, 2,   NAD↓, 1,   NADPH↓, 1,   PDH↑, 2,   PDK1↓, 2,   PDKs↓, 1,   PFK↓, 1,   PKM2↓, 2,  

Cell Death

Akt↓, 7,   p‑Akt↓, 3,   Apoptosis↑, 8,   BAX↑, 5,   Bax:Bcl2↑, 1,   Bcl-2↓, 4,   Bcl-xL↓, 4,   BIM↑, 1,   Casp↑, 3,   Casp3↑, 7,   Casp9↑, 4,   Cyt‑c↑, 1,   GRP58↓, 1,   JNK↑, 3,   MAPK↓, 1,   Mcl-1↓, 2,   p27↑, 3,   p38↑, 1,   survivin↓, 2,  

Kinase & Signal Transduction

HER2/EBBR2↓, 1,  

Transcription & Epigenetics

other↓, 1,   other↝, 1,   tumCV↓, 2,  

Protein Folding & ER Stress

CHOP↑, 1,   ER Stress↑, 1,   GRP78/BiP↑, 1,   UPR↑, 1,  

Autophagy & Lysosomes

Beclin-1↓, 1,   LC3B-II↑, 1,   p62↓, 1,   p62↑, 1,   TumAuto↓, 1,  

DNA Damage & Repair

DNAdam↑, 1,   MGMT↓, 1,   P53↓, 1,   P53↑, 4,   p‑P53↑, 1,   PARP1↑, 1,   PCNA↓, 1,  

Cell Cycle & Senescence

Cyc↓, 1,   cycD1/CCND1↓, 1,   P21↑, 2,   TumCCA↑, 3,  

Proliferation, Differentiation & Cell State

ALDH↓, 1,   CD24↓, 1,   CD44↓, 1,   cFos↓, 1,   CSCs↓, 2,   EMT↓, 4,   ERK↓, 2,   GSK‐3β↓, 1,   IGF-1R↓, 4,   mTOR↓, 5,   p‑mTOR↑, 2,   p‑P70S6K↓, 1,   p‑P70S6K↑, 1,   PI3K↓, 2,   PI3K↝, 1,   STAT3↓, 1,   TumCG↓, 9,   TumCG↑, 1,   TumCG∅, 1,  

Migration

E-cadherin↑, 1,   FAK↓, 1,   Furin↓, 4,   ITGB1↓, 2,   ITGB3↓, 1,   Ki-67↓, 1,   MMP11↓, 1,   MMP2↓, 2,   MMP9↓, 4,   MMPs↓, 1,   MUC4↓, 1,   NeuroT↓, 1,   p‑SMAD2↓, 1,   Snail↓, 2,   TGF-β↓, 1,   TumCI↓, 3,   TumCMig↓, 5,   TumCP↓, 3,   TumMeta↓, 2,   Twist↓, 1,   Vim↓, 2,   Zeb1↓, 1,   β-catenin/ZEB1↓, 1,  

Angiogenesis & Vasculature

angioG↓, 2,   EGFR↓, 2,   EGR4↓, 1,   Hif1a↓, 1,   Hif1a↑, 2,   PDI↑, 1,  

Immune & Inflammatory Signaling

COX2↓, 1,   IKKα↓, 1,   Inflam↓, 1,   NF-kB↓, 3,   NF-kB↑, 1,   PSA↓, 1,   TNF-α↓, 1,  

Hormonal & Nuclear Receptors

BNP↓, 1,  

Drug Metabolism & Resistance

BioAv↝, 1,   ChemoSen↑, 4,   Dose↑, 1,   Dose↝, 1,   Dose∅, 2,   eff↓, 2,   eff↑, 3,   Half-Life↓, 1,   RadioS↑, 1,   selectivity↑, 4,  

Clinical Biomarkers

EGFR↓, 2,   HER2/EBBR2↓, 1,   Ki-67↓, 1,   PSA↓, 1,  

Functional Outcomes

AntiCan↑, 1,   chemoP↑, 1,   cognitive?, 1,   neuroP↑, 1,   OS↑, 6,   RenoP↑, 1,   TumVol↓, 1,   Weight↑, 1,   Weight∅, 1,  
Total Targets: 161

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↑, 25,   Catalase↑, 4,   GPx↑, 5,   GSH↑, 19,   GSR↑, 1,   GSSG↓, 1,   GSTs↑, 1,   H2O2↓, 1,   H2O2∅, 1,   HK1↑, 1,   HO-1↑, 5,   Iron↓, 1,   lipid-P↓, 9,   MDA↓, 3,   NOX4↓, 1,   NQO1↑, 3,   NRF2↑, 10,   ROS↓, 25,   ROS↑, 1,   SIRT3↑, 1,   SOD↑, 4,   SOD1↑, 1,   TAC↑, 1,   VitC↑, 4,   VitE↑, 4,  

Metal & Cofactor Biology

IronCh↑, 17,  

Mitochondria & Bioenergetics

ATP↑, 2,   MMP↑, 2,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis

ACC↑, 1,   Acetyl-CoA↑, 3,   adiP↑, 2,   ALAT↓, 1,   AMPK↑, 2,   AMPK⇅, 1,   BUN↓, 1,   cAMP↑, 2,   cMyc↓, 1,   FAO↑, 1,   glucose↑, 1,   GlucoseCon↑, 11,   Glycolysis↑, 1,   LDH↓, 1,   NADPH↑, 1,   PDH↑, 1,   PDKs↓, 1,   SIRT1↑, 2,  

Cell Death

Akt?, 1,   Akt↑, 3,   Apoptosis↓, 2,   Casp3↓, 2,   Casp6↓, 1,   Casp9↓, 3,   iNOS↓, 4,   JNK↓, 1,   MAPK↓, 1,   MAPK↑, 2,   p38↑, 1,  

Transcription & Epigenetics

Ach↑, 7,   other↓, 1,   other↑, 2,   other↝, 4,  

DNA Damage & Repair

ATM↑, 1,  

Proliferation, Differentiation & Cell State

CD34↑, 1,   ERK↑, 3,   FOXO1↑, 1,   FOXO3↑, 1,   IGF-1↑, 1,   PI3K↑, 3,   PTEN↓, 2,   STAT↓, 1,  

Migration

Ca+2↓, 1,   COL3A1↓, 1,   E-sel↓, 1,   MMP9↓, 2,   PKCδ↑, 2,   VCAM-1↓, 7,   α-SMA↓, 1,  

Angiogenesis & Vasculature

eNOS↓, 1,   eNOS↑, 1,   Hif1a↑, 3,   NO↓, 3,   VEGF↓, 1,   VEGF↑, 2,  

Barriers & Transport

BBB↑, 13,   GLUT1↑, 1,   GLUT3↑, 3,   GLUT4↑, 5,  

Immune & Inflammatory Signaling

COX2↓, 2,   ICAM-1↓, 3,   IL1β↓, 6,   IL2↓, 1,   IL6↓, 5,   IL8↓, 1,   INF-γ↓, 1,   Inflam↓, 17,   JAK↓, 1,   MCP1↓, 1,   NF-kB↓, 11,   p‑NF-kB↓, 1,   PGE2↓, 1,   TNF-α↓, 6,  

Synaptic & Neurotransmission

5HT↑, 2,   AChE↓, 2,   BDNF↑, 1,   ChAT↑, 7,   tau↓, 1,   p‑tau↓, 1,  

Protein Aggregation

Aβ↓, 7,  

Drug Metabolism & Resistance

BioAv↓, 3,   BioAv↑, 5,   BioAv↝, 7,   Dose↝, 1,   eff↓, 1,   eff↑, 5,   Half-Life↓, 4,  

Clinical Biomarkers

ALAT↓, 1,   ALP↓, 1,   AST↓, 1,   BG↓, 1,   BP↓, 1,   BP↝, 1,   creat↓, 1,   GutMicro↑, 1,   IL6↓, 5,   LDH↓, 1,  

Functional Outcomes

AntiAge↑, 3,   AntiCan↑, 1,   cardioP?, 1,   cardioP↓, 1,   cardioP↑, 3,   chemoP↑, 1,   cognitive↑, 17,   cognitive∅, 2,   hepatoP↑, 2,   memory↑, 10,   motorD↑, 3,   neuroP↑, 18,   radioP↑, 1,   RenoP↑, 1,   toxicity↓, 3,   toxicity∅, 1,   Weight↓, 1,  

Infection & Microbiome

Sepsis↓, 1,  
Total Targets: 144

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:29  Target#:%  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page